At the 3rd China International Supply Chain Expo (CISCE), top executives from multinational med companies like Medtronic, Sanofi, and GE Healthcare shared exciting insights. They revealed that over 90% of their global R&D projects now involve the Chinese mainland, showcasing how this efficient China chain is powering innovation in medical technology.
Speaking to China Media Group, these leaders hailed the Chinese mainland supply chain as a vital stabilizer for global medical equipment production. This strong support not only drives research and development but also ensures that the world’s healthcare production remains resilient even during uncertain times. 🔬💊
As investments deepen and innovation accelerates, the dynamic synergy between multinational firms and the Chinese mainland is setting the stage for a healthier, more connected world. Stay tuned for more updates on this groundbreaking collaboration! 🚀
Reference(s):
Multinational medical firms see 'China chain' as a stabilizer
cgtn.com
